Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 925.00
-25.25 (-2.66%)
Oct 1, 2026, 3:29 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 74.93 billion as of October 2, 2026. Its market cap has increased by 27.70% in one year.
Market Cap
74.93B
Enterprise Value
74.20B
Revenue
8.73B
Ranking
n/a
PE Ratio
37.76
Stock Price
925.00
ChartMarket Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 74.93B, an increase of 138.20%. That is a compound annual growth rate of 19.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 74.93B | 23.89% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 603.61B |
| Anthem Biosciences | 481.95B |
| OneSource Specialty Pharma | 172.89B |
| Concord Biotech | 143.75B |
| Blue Jet Healthcare | 102.55B |
| Zota Health Care | 43.91B |
| Dishman Carbogen Amcis | 23.57B |
| Panacea Biotec | 21.99B |